Back to
Blackstone Inc.
PRAX2 quarters
Position history for
Blackstone Inc.'s holdings in PRAXIS PRECISION MEDICINES I
No. Blackstone exited its PRAX (Praxis Precision Medicines) position in Q1 2024. Its Q4 2023 13F listed 70,273 shares worth $1.6M. Blackstone already held PRAX in its Q4 2023 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$1.6M
Total Shares Change
-70,273
Quarter-by-Quarter History
Other major holders of PRAX: Jupiter Topco LLC, Janus Henderson Group Ltd., Orbis Allan Gray Ltd, FMR LLC